Cytokinetics (CYTK) Presents Additional 48-Week Data From FOREST-HCM, the Open Label Extension Clinical Study of Aficamten

Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Cytokinetics+%28CYTK%29+Presents+Additional+48-Week+Data+From+FOREST-HCM%2C+the+Open+Label+Extension+Clinical+Study+of+Aficamten/23032449.html for the full story.